IGM Biosciences Inc (IGMS)
9.35
-0.10
(-1.06%)
USD |
NASDAQ |
May 02, 13:37
IGM Biosciences Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
Date | Value |
---|---|
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2022
--
Maximum
Jun 2022
--
Average
--
Median
Jun 2022
Debt to Equity Ratio Benchmarks
Inotiv Inc | 1.492 |
Synlogic Inc | 0.00 |
BioXcel Therapeutics Inc | -1.780 |
Xilio Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | 0.3431 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 423.41M |
Total Liabilities (Quarterly) | 220.18M |
Shareholders Equity (Quarterly) | 203.23M |
Current Ratio | 8.182 |